PODD
$PODD
Insulet Corporation
Medical device maker of Omnipod tubeless insulin delivery system for diabetes management.
HealthcareSubscribers
0
Tracking this ticker
Next Report
—
Weekly updates
Latest Report
PODD: Omnipod Growth vs Recall Risk
Insulet ($PODD) is trading near its 52-week low after a steep pullback despite strong adoption of Omnipod 5 and a strong analyst consensus. The story is now a balance between durable growth and short-term execution and quality risks ahead of Q1 results on May 6, 2026.
Apr 6, 2026